NGL FINECHEM
Back to Income Statement
|
NGL FINECHEM Last 5 Year Total Expenditure History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Expenditure | ₹249 Cr | ₹178 Cr | ₹13,192,719 Cr | ₹121 Cr | ₹121 Cr |
What is the latest Total Expenditure of NGL FINECHEM ?
Year | Total Expenditure |
---|---|
Mar2023 | ₹249 Cr |
Mar2022 | ₹178 Cr |
Mar2021 | ₹13,192,719 Cr |
Mar2020 | ₹121 Cr |
Mar2019 | ₹121 Cr |
How is Total Expenditure of NGL FINECHEM Trending?
Years | Total Expenditure | % Change | |
---|---|---|---|
Mar2023 | ₹249 Cr | 40.17 | |
Mar2022 | ₹178 Cr | -100.00 | |
Mar2021 | ₹13,192,719 Cr | 10,913,887.36 | |
Mar2020 | ₹121 Cr | 0.00 | |
Mar2019 | ₹121 Cr | - |
Compare Total Expenditure of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹1,636.5 Cr | 2.1% | 21.5% | 73.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹360,920.0 Cr | -2.3% | -6.5% | 55.3% | Stock Analytics | |
CIPLA | ₹113,794.0 Cr | 4.1% | -4.8% | 55.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹106,860.0 Cr | 7.8% | 17.4% | 20.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,316.0 Cr | 4% | 0.8% | 29.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,380.9 Cr | -1.2% | -5.2% | 83.9% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | 2.1% |
21.5% |
73.2% |
SENSEX | 0.9% |
1.5% |
23.6% |
You may also like the below Video Courses